口腔鳞状细胞癌嗜神经侵袭的研究进展

doi:10.7518/gjkq.2024043

摘要/Abstract

摘要：

口腔鳞状细胞癌（OSCC）是头颈部最常见的恶性肿瘤，具有侵袭、转移、复发的特点，严重影响患者的生命健康。嗜神经侵袭（PNI）是OSCC一个常见且隐匿的病理学特征，降低了患者的生存率，但目前临床上对这种肿瘤高危生物学行为的认识仍不足。近年的研究发现PNI是肿瘤与神经双向的信号交互过程，多种细胞、信号分子参与其中，有可能成为未来治疗干预的靶点。本文就OSCC中PNI的分子病理机制、对预后的影响和临床治疗的研究进展作一综述。

关键词: 口腔鳞状细胞癌, 嗜神经侵袭, 预后, 分子机制

Abstract:

Oral squamous cell carcinoma (OSCC) is the most common malignant tumor in the head and neck. OSCC seriously hampers patients’ life and health because of its invasion, metastasis, and recurrence characteristics. Perineural invasion (PNI) is a common but occult pathologic characteristic of OSCC that reduces the survival rate of patients. However, the clinical understanding of this high-rick biological behavior ability and mechanism remains insufficient. Recent studies have found that perineural invasion is a reciprocal communication between the tumor and nerves, which involves a variety of cells and molecules, and may become the target of future therapeutic intervention. This article reviews the research progress on the molecular pathological mechanism, prognostic value, and treatment of PNI in OSCC.

Key words: oral squamous cell carcinoma, perineural invasion, prognosis, molecular mechanism

中图分类号:

R781

李冰芷, 刘云坤, 王文轩, 侯泽宇, 唐金茹, 李龙江. 口腔鳞状细胞癌嗜神经侵袭的研究进展[J]. 国际口腔医学杂志, 2024, 51(3): 362-367.

Bingzhi Li, Yunkun Liu, Wenxuan Wang, Zeyu Hou, Jinru Tang, Longjiang Li. Research progress on perineural invasion of oral squamous cell carcinoma[J]. Int J Stomatol, 2024, 51(3): 362-367.

参考文献 45

1	王泽坤, 罗京伟. 头颈部恶性肿瘤嗜神经侵袭临床诊治现状[J]. 中华放射肿瘤学杂志, 2020, 29(2): 146-149.
	Wang ZK, Luo JW. Clinical diagnosis and treatment of perineural invasion of head and neck malignant tumors[J]. Chin J Radiat Oncol, 2020, 29(2): 146-149.
2	Misztal CI, Green C, Mei C, et al. Molecular and cellular mechanisms of perineural invasion in oral squamous cell carcinoma: potential targets for therapeutic intervention[J]. Cancers (Basel), 2021, 13(23): 6011.
3	Quintana DMVO, Dedivitis RA, Kowalski LP. Prognostic impact of perineural invasion in oral cancer: a systematic review[J]. Acta Otorhinolaryngol Ital, 2022, 42(1): 17-25.
4	Kurtz KA, Hoffman HT, Zimmerman MB, et al. Perineural and vascular invasion in oral cavity squamous carcinoma: increased incidence on re-review of slides and by using immunohistochemical enhancement[J]. Arch Pathol Lab Med, 2005, 129(3): 354-359.
5	Alkhadar H, Macluskey M, White S, et al. Perineural invasion in oral squamous cell carcinoma: incidence, prognostic impact and molecular insight[J]. J Oral Pathol Med, 2020, 49(10): 994-1003.
6	Liebig C, Ayala G, Wilks JA, et al. Perineural invasion in cancer: a review of the literature[J]. Cancer, 2009, 115(15): 3379-3391.
7	Kim RY, Helman JI, Braun TM, et al. Increased presence of perineural invasion in the tongue and floor of the mouth: could it represent a more aggressive oral squamous cell carcinoma, or do larger aggressive tumors cause perineural invasion[J]. J Oral Maxillofac Surg, 2019, 77(4): 852-858.
8	Schmitd LB, Perez-Pacheco C, Bellile EL, et al. Spatial and transcriptomic analysis of perineural invasion in oral cancer[J]. Clin Cancer Res, 2022, 28(16): 3557-3572.
9	Amit M, Na’ara S, Gil Z. Mechanisms of cancer dissemination along nerves[J].Nat Rev Cancer, 2016, 16(6): 399-408.
10	Zheng K, Lan T, Li GP, et al. Evaluated expression of CELSR3 in oral squamous cell carcinoma is associated with perineural invasion and poor prognosis[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2022, 133(5): 564-573.
11	Alkhadar H, Macluskey M, White S, et al. Nerve growth factor-induced migration in oral and salivary gland tumour cells utilises the PI3K/Akt signalling pathway: is there a link to perineural invasion[J]. J Oral Pathol Med, 2020, 49(3): 227-234.
12	Kolokythas A, Cox DP, Dekker N, et al. Nerve growth factor and tyrosine kinase A receptor in oral squamous cell carcinoma: is there an association with perineural invasion[J]. J Oral Maxillofac Surg, 2010, 68(6): 1290-1295.
13	Shen WR, Wang YP, Chang JY, et al. Perineural invasion and expression of nerve growth factor can predict the progression and prognosis of oral tongue squamous cell carcinoma[J]. J Oral Pathol Med, 2014, 43(4): 258-264.
14	Yu EH, Lui MT, Tu HF, et al. Oral carcinoma with perineural invasion has higher nerve growth factor expression and worse prognosis[J]. Oral Dis, 2014, 20(3): 268-274.
15	Maruya SI, Myers JN, Weber RS, et al. ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion[J]. Oral Oncol, 2005, 41(6): 580-588.
16	Zhang M, Xian HC, Dai L, et al. MicroRNAs: emerging driver of cancer perineural invasion[J]. Cell Biosci, 2021, 11(1): 117.
17	Yu EH, Tu HF, Wu CH, et al. MicroRNA-21 promotes perineural invasion and impacts survival in patients with oral carcinoma[J]. J Chin Med Assoc, 2017, 80(6): 383-388.
18	Chang KW, Chu TH, Gong NR, et al. miR-370 modu-lates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma[J]. Oral Dis, 2013, 19(6): 611-619.
19	Dou ZC, Gao L, Ren WH, et al. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metasta-tic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways[J]. Exp Cell Res, 2020, 396(2): 112290.
20	Deborde S, Omelchenko T, Lyubchik A, et al. Sch-wann cells induce cancer cell dispersion and invasion[J]. J Clin Invest, 2016, 126(4): 1538-1554.
21	Santi MD, Zhang M, Salvo E, et al. Schwann cells induce phenotypic changes in oral cancer cells[J]. Adv Biol (Weinh), 2022, 6(9): e2200187.
22	Ein L, Mei C, Bracho O, et al. Modulation of BDNF-TRKB interactions on schwann cell-induced oral squamous cell carcinoma dispersion in vitro [J]. Anticancer Res, 2019, 39(11): 5933-5942.
23	Tassone P, Caruso C, White M, et al. The role of matrixmetalloproteinase-2 expression by fibroblasts in perineural invasion by oral cavity squamous cell carcinoma[J]. Oral Oncol, 2022, 132: 106002.
24	Lin CZ, Cao W, Ren ZH, et al. GDNF secreted by nerves enhances PD-L1 expression via JAK2-STAT1 signaling activation in HNSCC[J]. Oncoimmunology, 2017, 6(11): e1353860.
25	Fu Y, Zhang XW, Ding Z, et al. Worst pattern of perineural invasion redefines the spatial localization of nerves in oral squamous cell carcinoma[J]. Front Oncol, 2021, 11: 766902.
26	Spoerl S, Spoerl S, Reil S, et al. Prognostic value of perineural invasion on survival and recurrence in oral squamous cell carcinoma[J]. Diagnostics (Basel), 2022, 12(5): 1062.
27	Cracchiolo JR, Xu B, Migliacci JC, et al. Patterns of recurrence in oral tongue cancer with perineural invasion[J]. Head Neck, 2018, 40(6): 1287-1295.
28	Nair D, Mair M, Singhvi H, et al. Perineural invasion: independent prognostic factor in oral cancer that warrants adjuvant treatment[J]. Head Neck, 2018, 40(8): 1780-1787.
29	Yang X, Tian XR, Wu KL, et al. Prognostic impact of perineural invasion in early stage oral tongue squamous cell carcinoma: results from a prospective randomized trial[J]. Surg Oncol, 2018, 27(2): 123-128.
30	Ting KC, Lee TL, Li WY, et al. Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3-4 oral squamous cell carcinoma[J]. Sci Rep, 2021, 11(1): 19770.
31	Caponio VCA, Troiano G, Togni L, et al. Pattern and localization of perineural invasion predict poor survival in oral tongue carcinoma[J]. Oral Dis, 2023, 29(2): 411-422.
32	Lee LY, de Paz D, Lin CY, et al. Prognostic impact of extratumoral perineural invasion in patients with oral cavity squamous cell carcinoma[J]. Cancer Med, 2019, 8(14): 6185-6194.
33	Zhang Y, Chen MT, Liu ZQ, et al. The neuropeptide calcitonin gene-related peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma[J]. BMC Cancer, 2021, 21(1): 1254.
34	Jin WY, Zhu M, Zheng Y, et al. Perineural invasion, lactate dehydrogenase, globulin, and serum sodium predicting occult metastasis in oral cancer[J]. Oral Dis, 2022, 28(1): 132-141.
35	Li JJ, Liu S, Li ZG, et al. Prognostic value of perineural invasion in oral tongue squamous cell carcinoma: a systematic review and meta-analysis[J]. Front Oncol, 2021, 11: 683825.
36	Hasmat S, Ebrahimi A, Gao K, et al. Multifocal perineural invasion is a better prognosticator than depth of invasion in oral squamous cell carcinoma[J]. Head Neck, 2019, 41(11): 3992-3999.
37	Chatzistefanou I, Lubek J, Markou K, et al. The role of perineural invasion in treatment decisions for oral cancer patients: a review of the literature[J]. J Cranio-maxillofac Surg, 2017, 45(6): 821-825.
38	Hatten KM, Gupta N, Strome SE. What additional treatment is indicated for oral cavity cancer with isolated perineural invasion[J]. Laryngoscope, 2017, 127(9): 1965-1966.
39	Tai SK, Li WY, Yang MH, et al. Treatment for T1-2 oral squamous cell carcinoma with or without perineural invasion: neck dissection and postoperative adjuvant therapy[J]. Ann Surg Oncol, 2012, 19(6): 1995-2002.
40	Feng ZE, Cheng AM, Alzahrani S, et al. Elective neck dissection in T1N0M0 oral squamous cell carcinoma: when is it necessary[J]. J Oral Maxillofac Surg, 2020, 78(12): 2306-2315.
41	Alzahrani S, Feng ZE, Cheng AM, et al. Is perineural invasion a reasonable indicator for neck dissection in cT1N0M0 squamous cell carcinoma of the oral cavity[J]. J Oral Maxillofac Surg, 2021, 79(3): 704-711.
42	Nguyen E, McKenzie J, Clarke R, et al. The indications for elective neck dissection in T1N0M0 oral cavity squamous cell carcinoma[J]. J Oral Maxillofac Surg, 2021, 79(8): 1779-1793.
43	Vonk J, Smit KA, Roodenburg JLN, et al. Effect of adjuvant radiotherapy on the local recurrence of oral squamous cell carcinoma with perineural invasion: a systematic review[J]. Clin Otolaryngol, 2019, 44(2): 131-137.
44	Rajappa SK, Ram D, Shukla H, et al. Oncological benefits of postoperative radiotherapy in node-negative early stage cancer of the oral cavity with isola-ted perineural invasion[J]. Br J Oral Maxillofac Surg, 2019, 57(5): 454-459.
45	Fan KH, Chen YC, Lin CY, et al. Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score matching analysis[J]. Radiat Oncol, 2017, 12(1): 184.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

[1]	武旭,达林泰,苏尼特,尚多,周兴安,德乐黑巴特尔. CXCL趋化因子在头颈部鳞状细胞癌中的表达及临床意义[J]. 国际口腔医学杂志, 2024, 51(3): 303-309.
[2]	成应琪,黄正蔚. 上颌窦解剖结构及其与上颌后牙显微根尖手术的关系[J]. 国际口腔医学杂志, 2024, 51(2): 151-156.
[3]	王文轩,刘云坤,李冰芷,黄能文,侯泽宇,唐金茹,李龙江. 晚期糖基化终产物在口腔鳞状细胞癌发展及治疗的研究进展[J]. 国际口腔医学杂志, 2024, 51(2): 208-216.
[4]	周金阔,张晋弘,史晓晶,刘广顺,姜磊,刘倩峰. 长链非编码RNA小核仁RNA宿主基因22调控微小RNA-27b-3p对口腔鳞状细胞癌细胞增殖、侵袭和迁移的影响[J]. 国际口腔医学杂志, 2024, 51(1): 52-59.
[5]	李立恒,王蕊,王晓明,张智轶,张璇,安峰,王芹,张凡. 环状RNA hsa_circ_0085576调控微小RNA-498/B细胞特异性莫洛尼鼠白血病病毒整合位点1轴对口腔鳞状细胞癌细胞迁移和侵袭的影响[J]. 国际口腔医学杂志, 2024, 51(1): 60-67.
[6]	吴佳敏,夏斌,杨禾丰,许彪. 癌相关成纤维细胞在口腔鳞状细胞癌微环境中作用的研究进展[J]. 国际口腔医学杂志, 2023, 50(6): 711-717.
[7]	柳江龙, 买买提吐逊·吐尔地. 超声造影在口腔鳞状细胞癌颈部转移性淋巴结诊断中的研究进展[J]. 国际口腔医学杂志, 2023, 50(5): 514-520.
[8]	盛南宁,王珏,南欣荣. 性别决定基因盒9在口腔鳞状细胞癌作用机制和治疗中的研究进展[J]. 国际口腔医学杂志, 2023, 50(3): 314-320.
[9]	王婧妍,秦满,王欣. Axenfeld-Rieger综合征的口腔颌面部临床特点及相关成对同源结构域转录因子2基因突变的致病机制研究进展[J]. 国际口腔医学杂志, 2023, 50(2): 224-229.
[10]	李潭,梁新华. 盘状蛋白结构域受体1在调控恶性肿瘤进展和治疗中的作用[J]. 国际口腔医学杂志, 2023, 50(2): 230-236.
[11]	赵卓平,辛鹏飞,高阳,张彩凤,张宽收,刘青梅. 光热治疗在口腔鳞状细胞癌治疗中的研究进展[J]. 国际口腔医学杂志, 2022, 49(4): 462-470.
[12]	江涵,神应强,陈谦明. 毒蕈碱受体通过Yes相关蛋白信号对口腔鳞状细胞癌生物学行为的实验研究[J]. 国际口腔医学杂志, 2022, 49(2): 138-143.
[13]	白皓亮,杨禾,赵蕾. 牙周病风险评估及预后判断工具的研究进展[J]. 国际口腔医学杂志, 2021, 48(6): 696-702.
[14]	蒋宇磊,夏斌,饶南荃,杨禾丰,许彪. 外泌体在口腔鳞状细胞癌恶性进展及诊疗应用的研究[J]. 国际口腔医学杂志, 2021, 48(6): 711-717.
[15]	马平川,李春洁,李龙江. 唾液腺导管癌的诊疗研究进展[J]. 国际口腔医学杂志, 2021, 48(4): 459-467.